Skip to content
Review

Technical limitations of CRISPR-Cas9 genome editing in bacteria: challenges and future directions

Sep 2026 · Archives of Microbiology · Vol 208 · 0 citations · 120 references
Medicine

TL;DR

The principal barriers to CRISPR-Cas9 genome editing of bacteria are discussed, the current strategies for addressing these barriers are evaluated, and emerging approaches aimed at improving the efficiency, reliability and precision in bacterial genome engineering are highlighted.

View source

Similar papers

#gene editing Review Open access Sep 2026

CRISPR/Cas Systems: Biological Basis and Genome Editing Applications.

Clustered regularly interspaced short palindromic repeats (CRISPR) and associated (Cas) systems have revolutionized the field of genome engineering by providing versatile, efficient, and programmable tools for precise genetic manipulation. Originally identified as an adaptive immune mechanism in prokaryotes, CRISPR/Cas...

E. Cakiroglu, Serif Senturk · 0 citations
#gene editing Review Sep 2026

Advances in CRISPR-Based Genetic Engineering of Bifidobacterium.

Where genetic accessibility can be established, the integration of CRISPR technology with synthetic biology may enable more precise gene regulation and could support the development of next-generation engineered Bifidobacterium-based platforms.

Xiao-Tong Lin, Yi-Xin Zhang, Jia-Yi Cheng et al. · 0 citations
Review Open access Sep 2026

A review of the application of CRISPR-Cas in microbial biotechnology

Today, the use of CRISPR-Cas systems for genome editing and modification in diverse microbial species is widespread. Originally identified as bacterial defense mechanisms against viral invaders, CRISPR-Cas systems are present across a broad spectrum of microbial taxa, including bacteria and archaea. These systems are c...

B. Nowruzi, Hassan Beiranvand, Armita Biglari · 0 citations
#gene editing Review Sep 2026

CRISPR–Cas9 genome editing: technological advances, delivery strategies and precision engineering of primary cells for therapeutic application in genetic disorders and diabetes mellitus

Recent advances in CRISPR-Cas9–mediated genome editing are highlighted, emphasizing breakthroughs in primary cell editing and the development of translational models for genetic diseases and diabetes mellitus.

Md Nur Islam, Md. Mahmudul Islam, Han Feng et al. · 0 citations
#gene editing Review Open access Aug 2026

CRISPR gene therapy: a review

Clinical applicability is limited by issues such off-target effects, PAM sequence restrictions, DNA damage-induced toxicity, and immunological responses to Cas proteins, despite its wide therapeutic potential, but improvements in delivery methods and high-fidelity Cas9 variations are being addressed.

Sanjeyan N., G. G., H. S et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.